| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 993 | 24 | 1252 | 97 | 1181 | 211 | 1284 |
| ERLYTX | 94 | 1 | 52 | 4 | 49 | 11 | 67 |
| GI | 194 | 4 | 209 | 15 | 183 | 31 | 189 |
| GU | 438 | 2 | 104 | 31 | 377 | 70 | 426 |
| LEUK | 142 | 3 | 157 | 13 | 158 | 26 | 158 |
| LUNG | 200 | 5 | 261 | 18 | 219 | 34 | 207 |
| LYMPH | 395 | 5 | 261 | 38 | 463 | 64 | 390 |
| MELAN | 285 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 162 | 3 | 157 | 5 | 61 | 15 | 91 |
| MULT | 22 | 3 | 157 | 7 | 85 | 16 | 97 |
| OTHER | 38 | 0 | 0 | 4 | 49 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2970 | 51 | 2662 | 234 | 2849 | 485 | 2951 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 120 | 8 | 417 | 18 | 219 | 33 | 201 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 670 | 12 | 626 | 48 | 584 | 104 | 633 |
| LUNG | 302 | 8 | 417 | 33 | 402 | 65 | 396 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 37 | 1 | 52 | 5 | 61 | 11 | 67 |
| PEOLC | 128 | 5 | 261 | 19 | 231 | 38 | 231 |
| PREV | 214 | 6 | 313 | 21 | 256 | 43 | 262 |
| SURV | 19 | 0 | 0 | 4 | 49 | 8 | 49 |
| SXQOL | 576 | 7 | 365 | 47 | 572 | 100 | 609 |
| Total | 2077 | 47 | 2451 | 195 | 2374 | 403 | 2454 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 993 | 24 | 1252 | 97 | 1181 | 211 | 1284 |
| CCD | 120 | 8 | 417 | 18 | 219 | 33 | 201 |
| ERLYTX | 104 | 1 | 52 | 4 | 49 | 12 | 73 |
| GI | 194 | 4 | 209 | 15 | 183 | 31 | 189 |
| GU | 438 | 2 | 104 | 31 | 377 | 70 | 426 |
| LEUK | 812 | 15 | 783 | 61 | 743 | 130 | 791 |
| LUNG | 502 | 13 | 678 | 51 | 621 | 99 | 603 |
| LYMPH | 396 | 5 | 261 | 38 | 463 | 64 | 390 |
| MELAN | 285 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 162 | 3 | 157 | 5 | 61 | 15 | 91 |
| MULT | 22 | 3 | 157 | 7 | 85 | 16 | 97 |
| OTHER | 75 | 1 | 52 | 9 | 110 | 16 | 97 |
| PEOLC | 128 | 5 | 261 | 19 | 231 | 38 | 231 |
| PREV | 217 | 6 | 313 | 21 | 256 | 43 | 262 |
| SURV | 19 | 0 | 0 | 4 | 49 | 8 | 49 |
| SXQOL | 578 | 7 | 365 | 47 | 572 | 100 | 609 |
| Total | 5047 | 98 | 5113 | 429 | 5224 | 888 | 5405 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 608 | 12 | 626 | 57 | 694 | 134 | 816 |
| ERLYTX | 52 | 1 | 52 | 3 | 37 | 8 | 49 |
| GI | 140 | 1 | 52 | 10 | 122 | 22 | 134 |
| GU | 367 | 2 | 104 | 23 | 280 | 53 | 323 |
| LEUK | 86 | 1 | 52 | 8 | 97 | 14 | 85 |
| LUNG | 127 | 2 | 104 | 7 | 85 | 16 | 97 |
| LYMPH | 252 | 2 | 104 | 28 | 341 | 39 | 237 |
| MELAN | 180 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 103 | 3 | 157 | 4 | 49 | 8 | 49 |
| MULT | 8 | 1 | 52 | 2 | 24 | 5 | 30 |
| OTHER | 38 | 0 | 0 | 4 | 49 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1968 | 26 | 1355 | 148 | 1802 | 306 | 1862 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 107 | 7 | 365 | 16 | 195 | 28 | 170 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 304 | 4 | 209 | 23 | 280 | 48 | 292 |
| LUNG | 186 | 6 | 313 | 21 | 256 | 43 | 262 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 37 | 1 | 52 | 5 | 61 | 11 | 67 |
| PEOLC | 91 | 4 | 209 | 15 | 183 | 30 | 183 |
| PREV | 214 | 6 | 313 | 21 | 256 | 43 | 262 |
| SURV | 19 | 0 | 0 | 4 | 49 | 8 | 49 |
| SXQOL | 390 | 6 | 313 | 31 | 377 | 63 | 384 |
| Total | 1359 | 34 | 1774 | 136 | 1657 | 275 | 1675 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 791 | 14 | 730 | 67 | 816 | 163 | 992 |
| CCD | 135 | 4 | 209 | 15 | 183 | 35 | 213 |
| ERLYTX | 62 | 1 | 52 | 3 | 37 | 9 | 55 |
| GI | 145 | 0 | 0 | 10 | 122 | 24 | 146 |
| GU | 390 | 4 | 209 | 28 | 341 | 58 | 353 |
| LEUK | 390 | 5 | 261 | 31 | 377 | 62 | 377 |
| LUNG | 314 | 8 | 417 | 28 | 341 | 59 | 359 |
| LYMPH | 253 | 2 | 104 | 28 | 341 | 39 | 237 |
| MELAN | 180 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 99 | 3 | 157 | 4 | 49 | 8 | 49 |
| MULT | 22 | 1 | 52 | 2 | 24 | 7 | 43 |
| OTHER | 250 | 2 | 104 | 18 | 219 | 43 | 262 |
| PEOLC | 95 | 3 | 157 | 14 | 170 | 29 | 177 |
| PREV | 217 | 6 | 313 | 21 | 256 | 43 | 262 |
| SURV | 19 | 0 | 0 | 4 | 49 | 8 | 49 |
| SXQOL | 392 | 6 | 313 | 31 | 377 | 63 | 384 |
| Total | 3756 | 60 | 3130 | 306 | 3726 | 652 | 3970 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 840 | 16 | 835 | 77 | 937 | 166 | 1011 |
| ERLYTX | 90 | 1 | 52 | 4 | 49 | 10 | 61 |
| GI | 109 | 1 | 52 | 8 | 97 | 18 | 110 |
| GU | 250 | 1 | 52 | 21 | 256 | 46 | 280 |
| LEUK | 108 | 0 | 0 | 8 | 97 | 19 | 116 |
| LUNG | 169 | 5 | 261 | 15 | 183 | 30 | 183 |
| LYMPH | 320 | 5 | 261 | 29 | 353 | 52 | 317 |
| MMYEL | 151 | 3 | 157 | 5 | 61 | 14 | 85 |
| MULT | 22 | 3 | 157 | 7 | 85 | 16 | 97 |
| Total | 2059 | 35 | 1827 | 174 | 2118 | 371 | 2260 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1955 | 34 | 1774 | 178 | 2167 | 354 | 2155 |
| AFFIL | 118 | 3 | 157 | 13 | 158 | 27 | 164 |
| CCOP/NCORP | 1254 | 23 | 1200 | 93 | 1132 | 200 | 1218 |
| Non-SWOG | 1714 | 32 | 1670 | 139 | 1692 | 301 | 1832 |
| Total | 5041 | 92 | 4801 | 423 | 5149 | 882 | 5369 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| MMYEL | S2005 | WM, Prev. Untreated, I/R +/- Venetoclax | 1 | T | 20-NOV-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 12 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 11 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 9 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 8 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 7 |
| CCD | S1703 | Met Breast, STM-monitoring v Usual Care | 2 | 5 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 5 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | 4 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 4 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 3 |
| PREV | NRGCC005 | Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs | 1 | 3 |
| LUNG | S1800E | Non-Match: Docetaxel + Ramu +/- Cemiplimab | 1 | 3 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 2 | 3 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 1 | 3 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 3 |
| MMYEL | S2209 | MM, Newly Dx, VRd-R->R v DRd-R->R v DRD-DR->D | 1 | 3 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 3 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | 3 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 3 |